Before joining KKR, Shorthouse held a senior role dealing with ultra-wealthy individuals in Europe at Credit Suisse and earlier worked at UBS Group AG and Merrill Lynch. Outside finance, the ...

As the global private equity industry took tentative steps toward recovery in 2024, Japan raced ahead. Read more here.

The Department of Justice (“DOJ”) has alleged in a complaint filed in the Southern District of New York on January 14, 2025 that KKR & Co. Inc.

Learn more about whether KKR & Co. Inc. or UBS Group AG is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

In the assessment of 12-month price targets, analysts unveil insights for KKR, presenting an average target of $169.0, a high estimate of $185.00, and a low estimate of $151.00. This current average ...

Fintel reports that on January 30, 2025, HSBC downgraded their outlook for KKR (NYSE:KKR) from Buy to Hold. Analyst Price Forecast Suggests 3.79% Upside As of January 29, 2025, the average one-year ...

Alternative investment manager KKR & Co. has appointed Melissa Kivett as the firm’s first head of defined contribution, a ...

Private equity firm KKR & Co. Inc. has invested $250 million in Henry Schein Inc., Long Island’s largest publicly traded ...

Henry Schein Inc., a leading healthcare solutions provider, has secured a $250 million investment from private equity ...

KKR is set to become the largest non-index fund shareholder in Henry Schein, acquiring a 12% stake through a $250 million investment.

Henry Schein announced today that private equity firm KKR is investing $250 million in the medical products manufacturer and ...

Finally, we have a deal from KKR which has made an investment in healthcare and dental care provider Henry Schein.